07:00 , Mar 11, 2013 |  BC Week In Review  |  Company News

Oncomatrix sales and marketing update

Oncomatrix launched DMTXinvaScan immunohistochemistry kit worldwide to diagnose and prognose the invasiveness of tumors. The DMTXinvaScan uses a mAb developed by Oncomatrix to detect collagen type XI alpha 1 (COL11A1) gene and its encoded protein,...